Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Sudarshan Pharma Industries published a postal ballot notice for shareholder approval. Key resolutions include migrating from BSE SME to the Main Board, listing on NSE, and appointing two new directors. This move aims to enhance market visibility and corporate governance.
May 26 2026 10:32:00
Sudarshan Pharma Industries Ltd - 543828 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Sudarshan Pharma conducts postal ballot for a strategic move to migrate equity shares from the BSE SME Platform to BSE Main Board and NSE Main Board. This aims to boost market recognition and investor participation. Shareholders will also vote on two director appointments.
May 25 2026 14:40:23
Sudarshan Pharma Industries Ltd - 543828 - Revision Of Disclosure Made By The Company Under Paragraph 2.1(F) Of The Master Circular Compliance With The Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 By Listed Entities.
Sudarshan Pharma Industries has revised the conversion rate for its Foreign Currency Convertible Bond (FCCB) issue. The new fixed exchange rate for the USD 20 million FCCB will be Rs.96.8441 per US Dollar, updated from the earlier Rs.95.93 per US Dollar.
May 21 2026 12:48:11
Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Allotment
Sudarshan Pharma Industries allotted US$10 million in 8% Foreign Currency Convertible Bonds (FCCBs) due 2029. These bonds are convertible into equity shares at Rs.30.19 each. The company also holds an option for an additional US$10 million allotment.
May 21 2026 12:35:57
Sudarshan Pharma Industries Ltd - 543828 - Update on board meeting
Sudarshan Pharma's board meeting, originally scheduled for May 22, 2026, has been pre-poned to May 21, 2026. The agenda includes considering the migration of the company's equity shares from the SME Platform to the Main Boards of BSE and NSE, subject to shareholder approval.
May 18 2026 21:02:17
Sudarshan Pharma Industries Ltd - 543828 - Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On Friday, 22Nd May, 2026
Sudarshan Pharma's Board will convene on May 22, 2026, to discuss and approve the migration of its equity shares from the SME Platform to the Main Board of BSE and for listing on the Main National Stock Exchange (NSE). This move aims to enhance market visibility and liquidity.
May 18 2026 18:10:37
Sudarshan Pharma Industries Ltd - 543828 - Email By BSE Seeking Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Announcement Dated 15/05/2026
Sudarshan Pharma Industries board has approved the issuance of up to USD 20 million in 8.00% Senior Unsecured Foreign Currency Convertible Bonds (FCCBs) due 2029. This international offering will open on May 18, 2026, and could potentially result in the issuance of approximately 6.35 crore equity shares upon conversion.
May 18 2026 13:19:17
Read More